MY

MARILYN YAGER

ALSTON & BIRD LLP · WASHINGTON, DC · registered since 2024
Registered · LDAActive

Background

Government experience
Deputy Assistant to the President
White House Office of Public Liaison.
Disclosed on LD-2 filings
Career
WASHINGTON, DC
2024 - present

Specific issues

Hospital issues, including Medicare and Medicaid-related hospital issues. - H.R. 8702 / S. 4518, Improving Seniors Timely Access to Care Act - Legislation related to Support for Rural Hospitals (i.e. H.R. 1565, Critical Access Hospital Relief Act, S. 1571, Rural Hospital Closure Relief Act) - Support for extension of COVID-19 era telehealth flexibilities.. - Oppose Site Neutral Payment Policy Cuts - Cybersecurity
Medicare/Medicaid · 2024 Q3
Hospital issues, including Medicare and Medicaid-related hospital issues. - H.R. 8702/S. 4518, Improving Seniors Timely Access to Care Act. - Legislation related to Support for Rural Hospitals (i.e. H.R. 1565, Critical Access Hospital Relief Act, S. 1571, Rural Hospital Closure Relief Act) - Support for extension of COVID-19 era telehealth flexibilities - Oppose Site Neutral Payment Policy Cuts - Cybersecurity - Appropriations request to support rural labor and delivery services - Workforce Issues (i.e. H.R. 2389 / S. 1302, Resident Physician Shortage Reduction Act, H.R. 6205 / S. 3211, Healthcare Workforce Resilience Act, H.R. 4942 / S. 665, Conrad State 30 and Physician Access Reauthorization Act, H.R. 7266 / S. 3770, Future Advancement of Academic Nursing Act)
Health Issues · 2024 Q3
Support for H.R.5539 - Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation impacting products approved under the Accelerated Approval pathway. H.R.6790, New Era of Preventing End-Stage Kidney Disease Act. Policies regarding copay accumulators and impact on rare disease patients.
Medicare/Medicaid · 2024 Q3
Support for H.R.5539 - Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. Legislation regarding newborn screening. H.R.6790, New Era of Preventing End-Stage Kidney Disease Act. Policies regarding copay accumulators and impact on rare disease patients.
Health Issues · 2024 Q3
Funding for Disproportionate Share Hospitals (Medicaid DSH). Support for H.R.7327 - Protecting Front Line Multimission Hospitals Act of 2024. Support of telehealth policies, including for audio-only telehealth services. H.R.7053/S.3792 - acute hospital care at home waiver flexibility. H.R.3561, Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023. H.R.5378, Lower Costs, More Transparency Act; Medicare physician payment reductions, in general. H.R.6545, Physician Fee Schedule Update and Improvements Act. S.3430, Better Mental Health Care, Lower-Cost Drugs, and Extenders Act (provisions related to Medicare physician payment). H.R.2474, Strengthening Medicare for Patients and Providers Act. S.3450, Mental and Physical Health Care Comorbidities Act of 2023. In general, support provisions to reform Medicare physician fee schedule payment policies and access to physician services.
Medicare/Medicaid · 2024 Q3
Support for H.R.7327 - Protecting Front Line Multimission Hospitals Act of 2024. Sustainability of safety net health systems. Social determinants of health. Support of telehealth policies, including for audio-only telehealth services. 340B Protect Act, H.R.4390. H.R.3290, To amend Title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program. H.R.2665, Supporting Safety Net Hospitals Act. H.R.3561, Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023. Support for policies to enhance health care workforce programs. H.R.5378, Lower Costs, More Transparency Act. S.3548, Health Care Prices Revealed and Information to Consumers Explained Transparency Act. S.3450, Mental and Physical Health Care Comorbidities Act of 2023.
Health Issues · 2024 Q3

Clients

2024 · 4 filings
$██,███ / qtrUnlock
$██,███ / qtrUnlock
2024 · 4 filings
$██,███ / qtrUnlock
$██,███ / qtrUnlock
$██,███ / qtrUnlock
2024 · 3 filings
$██,███ / qtrUnlock
$██,███ / qtrUnlock
$██,███ / qtrUnlock
2024 · 3 filings
$██,███ / qtrUnlock
$██,███ / qtrUnlock
$██,███ / qtrUnlock
$██,███ / qtrUnlock
2024 · 3 filings
$██,███ / qtrUnlock
2024 · 3 filings
$██,███ / qtrUnlock
$██,███ / qtrUnlock
$██,███ / qtrUnlock
2024 · 2 filings
$██,███ / qtrUnlock
$██,███ / qtrUnlock

Filing history

2024 Q3
APPRISE HEALTH INSIGHTS
Q3lda.gov →
2024 Q3
COLORADO HOSPITAL ASSOCIATION
Q3lda.gov →
2024 Q3
REGIONAL ONE HEALTH
Q3lda.gov →
2024 Q3
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
Q3lda.gov →
2024 Q3
HOSPITAL ASSOCIATION OF OREGON
Q3lda.gov →
2024 Q3
HOLOGIC, INC.
Q3lda.gov →
2024 Q3
MASSACHUSETTS HOSPITAL ASSOCIATION
Q3lda.gov →
2024 Q3
THE METROHEALTH SYSTEM
Q3lda.gov →
2024 Q3
AVERA HEALTH
Q3lda.gov →
2024 Q3
DANA-FARBER CANCER INSTITUTE, INC.
Q3lda.gov →
2024 Q3
TENNESSEE HOSPITAL ASSOCIATION
Q3lda.gov →
2024 Q3
TRAVERE THERAPEUTICS
Q3lda.gov →
Showing recent filings · full history on lda.gov